DOI QR코드

DOI QR Code

Paclitaxel Coating Inhibits Inflammation Surrounding Subcutaneously Implanted Expanded Polytetrafluoroethylene (ePTFE) Hemodialysis Grafts in Rabbit Model

  • Baek, In-Su (School of Chemistry & Molecular Engineering, Seoul National University) ;
  • Lee, Yu-Ji (Division of Nephrology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Soo-Jin (Division of Nephrology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Bai, Cheng Zhe (School of Chemistry & Molecular Engineering, Seoul National University) ;
  • Park, Jong-Sang (School of Chemistry & Molecular Engineering, Seoul National University) ;
  • Kim, Dae-Joong (Division of Nephrology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Published : 2010.02.20

Abstract

Hemodialysis vascular access dysfunction (HVAD) due to the aggressive development of venous neointimal hyperplasia remains a major complication for patients with synthetic arteriovenous grafts. Paclitaxel-coated expanded polytetrafluoroethylene (ePTFE) grafts effectively prevent neointimal hyperplasia and stenosis. However, perigraft inflammation or edema can be another complication of ePTFE grafts, preventing early cannulation. Three different types of ePTFE grafts, including grafts without paclitaxel coating (control group, n = 12), grafts with paclitaxel coating at a dose density of $0.61ug/mm^2$ (low concentration group, n = 12), and grafts with paclitaxel coating at a dose density of $1.15ug/mm^2$ (high concentration group, n = 12) were placed in the backs of 12 rabbits, simultaneously. Six rabbits were euthanized after one week and the remaining six were euthanized two weeks after implantation. Perigraft inflammation, graft wall inflammation, stromal cell proliferation, blood vessel formation, tissue necrosis and edema were analyzed for the grafts in each animal. Inflammation surrounding the paclitaxel-coated grafts was significantly reduced compared to the control group. Stromal cell layers were detected at the interface between the graft and the surrounding tissue in the control group, infiltrated into the graft interstices, and differentiated into myofibroblasts for graft healing. Paclitaxel-coated grafts inhibited stromal cell proliferation and infiltration into the graft wall. Tissue necrosis and edema were not detected in either of the paclitaxel-coated graft groups.

Keywords

References

  1. Konner, K. Blood Purif. 2006, 24(3), 287. https://doi.org/10.1159/000091345
  2. Am. J. Kidney Dis. 2003, 41(4 Suppl 2), v. https://doi.org/10.1016/S0272-6386(03)80001-X
  3. Hakim, R.; Himmelfarb, J. Kidney Int. 1998, 54(4), 1029. https://doi.org/10.1046/j.1523-1755.1998.00122.x
  4. Am. J. Kidney Dis. 2001, 37(1 Suppl 1), S137. https://doi.org/10.1016/S0272-6386(01)70007-8
  5. Lee, B. H.; Lee, J. E.; Lee, K. W.; Nam, H. Y.; Jeon, H. J.; Sung, Y. J.; Kim, J. S.; Lim, H. J.; Park, J. S.; Ko, J. Y.; Kim, D. J. Nephrol. Dial. Transplant. 2007, 22(10), 2800. https://doi.org/10.1093/ndt/gfm438
  6. Lim, H. J.; Nam, H. Y.; Lee, B. H.; Kim, D. J.; Ko, J. Y.; Park, J. S. Biotechnol. Prog. 2007, 23(3), 693. https://doi.org/10.1021/bp060338i
  7. Lee, B. H.; Nam, H. Y.; Kwon, T.; Kim, S. J.; Kwon, G. Y.; Jeon, H. J.; Lim, H. J.; Lee, W. K.; Park, J. S.; Ko, J. Y.; Kim, D. J. Nephrol. Dial. Transplant. 2006, 21(9), 2432. https://doi.org/10.1093/ndt/gfl070
  8. Nam, H. Y.; Kim, D. J.; Lim, H. J.; Lee, B. H.; Baek, I.; Park, S. H.; Park, J. S. Bull. Korean Chem. Soc. 2008, 29(2), 422. https://doi.org/10.5012/bkcs.2008.29.2.422
  9. Orgill, D.; Demling, R. H. Crit. Care Med. 1988, 16(9), 899. https://doi.org/10.1097/00003246-198809000-00016
  10. Busuttil, S. J.; Drumm, C.; Plow, E. F. BC Decker Inc.: 2005; p 230.
  11. Goldstein, L. J.; Helfend, L. K.; Kordestani, R. K. Neurosurgery 2002, 50(2), 412. https://doi.org/10.1097/00006123-200202000-00035
  12. Matsuda, H.; Miyazaki, M.; Oka, Y.; Nakao, A.; Choda, Y.; Kokumai, Y.; Kunitomo, K.; Tanaka, N. Artificial Organs 2003, 27(8), 722. https://doi.org/10.1046/j.1525-1594.2003.07031.x
  13. Sunderkotter, C.; Steinbrink, K.; Goebeler, M.; Bhardwaj, R.; Sorg, C. J. Leukoc. Biol. 1994, 55(3), 410.
  14. Sunderkotter, C.; Goebeler, M.; Schulze-Osthoff, K.; Bhardwaj, R.; Sorg, C. Pharmacol. Ther. 1991, 51(2), 195. https://doi.org/10.1016/0163-7258(91)90077-Y
  15. Salzmann, D. L.; Kleinert, L. B.; Berman, S. S.; Williams, S. K. Cardiovasc. Pathol. 1999, 8(2), 63. https://doi.org/10.1016/S1054-8807(98)00003-9
  16. Chaponnier, C.; Gabbiani, G. J. Pathol. 2004, 204(4), 386. https://doi.org/10.1002/path.1635
  17. Tomasek, J. J.; McRae, J.; Owens, G. K.; Haaksma, C. J. Am. J. Pathol. 2005, 166(5), 1343. https://doi.org/10.1016/S0002-9440(10)62353-X
  18. Jin, D.; Ueda, H.; Takai, S.; Muramatsu, M.; Furubayashi, K.; Ibaraki, T.; Kishi, K.; Katsuoka, Y.; Miyazaki, M. Life Sciences 2007, 81(16), 1291. https://doi.org/10.1016/j.lfs.2007.09.004
  19. Tomasek, J. J.; Gabbiani, G.; Hinz, B.; Chaponnier, C.; Brown, R. A. Nat. Rev. Mol. Cell Biol. 2002, 3(5), 349. https://doi.org/10.1038/nrm809
  20. Storch, M.; Perry, L. C.; Davidson, J. M.; Ward, J. J. Surg. Infect (Larchmt) 2002, 3 Suppl 1, S89. https://doi.org/10.1089/sur.2002.3.s1-89
  21. Stronck, J. W.; van der Lei, B.; Wildevuur, C. R. J. Thorac. Cardiovasc. Surg. 1992, 103(1), 146.
  22. Brewster, L. P.; Bufallino, D.; Ucuzian, A.; Greisler, H. P. Biomaterials 2007, 28(34), 5028. https://doi.org/10.1016/j.biomaterials.2007.07.048
  23. Axel, D. I.; Kunert, W.; Goggelmann, C.; Oberhoff, M.; Herdeg, C.; Kuttner, A.; Wild, D. H.; Brehm, B. R.; Riessen, R.; Koveker, G.; Karsch, K. R. Circulation 1997, 96(2), 636. https://doi.org/10.1161/01.CIR.96.2.636
  24. Eisinger, D. R.; Sheil, A. G. Surg. Gynecol. Obstet. 1985, 160(2), 135.

Cited by

  1. Paclitaxel Coating on ePTFE Artificial Graft and the Release Behavior vol.36, pp.3, 2012, https://doi.org/10.7317/pk.2012.36.3.326
  2. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia vol.55, pp.3, 2010, https://doi.org/10.1016/j.jvs.2011.09.012
  3. New Coating Method for Sustained Drug Release: Surface Modification of ePTFE Grafts by inner coating PLGA vol.35, pp.5, 2010, https://doi.org/10.5012/bkcs.2014.35.5.1333
  4. The effect of the new hemostatic agent Ostene® on bone healing: An experimental study in rabbits. vol.7, pp.8, 2010, https://doi.org/10.17126/joralres.2018.075